Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patientsAdrián Curran, Esteban Ribera, Arkaitz Imaz et al.|Journal of Antimicrobial Chemotherapy|2016Cited by 10
Effectiveness and tolerability of abacavir‐lamivudine‐nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV‐infected, ARV‐naïve patientsDaniel Podzamczer, Nerea Rozas, Jhon Rojas et al.|Journal of the International AIDS Society|2014Cited by 2